Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Clinical trial NCT06190145 · UNKNOWN

Trial details

NCT number: NCT06190145
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2023-12-05
Primary completion: 2024-10-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.